Rockefeller Capital Management’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$611K Sell
13,735
-705
-5% -$25.4K ﹤0.01% 1984
2026
Q1
$465K Buy
14,440
+1,415
+11% +$50.3K ﹤0.01% 2014
2025
Q4
$469K Buy
13,025
+3,057
+31% +$112K ﹤0.01% 1941
2025
Q3
$314K Buy
+9,968
New +$358K ﹤0.01% 1997
2023
Q1
– Sell
-4,138
Closed -$108K – 3814
2022
Q4
$108K Sell
4,138
-328
-7% -$7.81K ﹤0.01% 1992
2022
Q3
$103K Buy
4,466
+4,312
+2,800% +$118K ﹤0.01% 1978
2022
Q2
$3K Buy
+154
New +$4.55K ﹤0.01% 3707

Other funds holding VCEL

Rockefeller Capital Management's VCEL Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Vericel Corp (VCEL) stake by 4.9% in Q2 2026, selling an estimated $25.4K and leaving 13,735 shares worth $611K. The position accounts for ﹤0.01% of the portfolio, ranked #1984.

Rockefeller Capital Management first reported a position in VCEL in Q2 2022 and has held it in 7 quarters since. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Rockefeller Capital Management held 13,735 shares of Vericel Corp worth $611K as of Q2 2026.
  • Rockefeller Capital Management sold 705 Vericel Corp shares in Q2 2026, an estimated $25.4K.
  • Vericel Corp made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1984 holding.
  • Rockefeller Capital Management first reported a position in Vericel Corp in Q2 2022 and has held it in 7 quarters since.
  • 320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.